Mesothelioma Legal News

Phase III Trial of Durvalumab for Mesothelioma Underway

The U.S. Food and Drug Administration will be closely watching the latest, international phase III clinical trial for unresectable pleural mesothelioma involving the immunotherapy drug durvalumab. FDA approval may be coming soon. “It looks very promising,” Dr. Arkadiusz Dudek, of Regions Hospital Cancer Care Center in St. Paul, Minnesota, told The Mesothelioma Center at Asbestos.com. […]

The post Phase III Trial of Durvalumab for Mesothelioma Underway appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

COVID Vaccine Gives Less Protection for Some Cancer Patients

Millions of people across the United States have begun receiving their COVID-19 vaccines, and restrictions are lifting in many public spaces such as restaurants and bars. Mesothelioma patients may be looking forward to returning to life as it was before the pandemic. However, a new study reports that the COVID-19 vaccine may not sufficiently protect […]

The post COVID Vaccine Gives Less Protection for Some Cancer Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Thoracic Surgeon Raja Flores Enters NYC Mayor’s Race

Thoracic surgeon and mesothelioma specialist Dr. Raja Flores wants to continue serving others, but in a new role as the next mayor of New York City. “Yes, I’m serious about this. Very serious,” Flores told The Mesothelioma Center at Asbestos.com Tuesday after another 14-hour workday and an evening surgery at Mount Sinai. “I want to […]

The post Thoracic Surgeon Raja Flores Enters NYC Mayor’s Race appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Some Mesothelioma Patients May Benefit from Second Radical Surgery

As overwhelming as major surgery for malignant pleural mesothelioma can be, there is a small cohort of patients who still would benefit from a second aggressive operation following the almost inevitable cancer recurrence. There are tangible returns, according to a recent study. Extended survival and better quality of life still can be attained. “A second […]

The post Some Mesothelioma Patients May Benefit from Second Radical Surgery appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

U.S. Asbestos Imports Increased Significantly in 2020

An estimated 300 metric tons of raw chrysotile asbestos was imported into the U.S. in 2020, almost doubling the amount from 2019, according to the recent United States Geological Survey Mineral Commodity Summaries report. The chloralkali industry accounted for 100% of the imports, all from Brazil. This industry uses the asbestos in the manufacturing of […]

The post U.S. Asbestos Imports Increased Significantly in 2020 appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

New Link Between Women with Mesothelioma and Survival Genes

Men with mesothelioma outnumber women four to one. However, numerous studies have shown that women with mesothelioma often have a survival advantage over men. Now, scientists might have a better understanding of why. Researchers have identified a gene that predicts the prognosis and treatment outcome for women with malignant pleural mesothelioma. The research took place […]

The post New Link Between Women with Mesothelioma and Survival Genes appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Legal Fight Continues Over Asbestos Disease in Libby, Mont.

The Center for Asbestos Related Disease in Libby, Montana, dodged a potential setback recently when officials from the U.S. Department of Justice decided against joining a lawsuit alleging fraudulent medical practices. Burlington Northern Santa Fe Railway filed the original suit in 2019 against the center – known as the CARD Clinic – alleging Medicare fraud […]

The post Legal Fight Continues Over Asbestos Disease in Libby, Mont. appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Legal Fight Continues Over Asbestos Disease in Libby, Mont.

The Center for Asbestos Related Disease in Libby, Montana, dodged a potential setback recently when officials from the U.S. Department of Justice decided against joining a lawsuit alleging fraudulent medical practices. Burlington Northern Santa Fe Railway filed the original suit in 2019 against the center – known as the CARD Clinic – alleging Medicare fraud…

The post Legal Fight Continues Over Asbestos Disease in Libby, Mont. appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Johnson & Johnson Preparing $3.9 Billion for Talc Settlements

Pharmaceutical giant Johnson & Johnson has set aside $3.9 billion for talc-related litigation, according to a regulatory filing this week with the Securities and Exchange Commission in Washington D.C. The company said it’s now facing more than 25,000 lawsuits related to various talc products that have allegedly caused cancers, primarily from asbestos fiber contamination. The $3.9 billion is almost […]

The post Johnson & Johnson Preparing $3.9 Billion for Talc Settlements appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Johnson & Johnson Preparing $3.9 Billion for Talc Settlements

Pharmaceutical giant Johnson & Johnson has set aside $3.9 billion for talc-related litigation, according to a regulatory filing this week with the Securities and Exchange Commission in Washington D.C. The company said it’s now facing more than 25,000 lawsuits related to various talc products that have allegedly caused cancers, primarily from asbestos fiber contamination. The…

The post Johnson & Johnson Preparing $3.9 Billion for Talc Settlements appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study: Which Mesothelioma Patients Will Immunotherapy Benefit?

Thoracic surgeon Dr. Bryan Burt at the Baylor College of Medicine wants to better identify which patients with pleural mesothelioma cancer will benefit (and which will not) from promising immunotherapy drugs such as Keytruda and Opdivo. No test currently exists to make that determination accurately, often leading to unnecessary treatments with adverse side effects and […]

The post Study: Which Mesothelioma Patients Will Immunotherapy Benefit? appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study: Which Mesothelioma Patients Will Immunotherapy Benefit?

Thoracic surgeon Dr. Bryan Burt at the Baylor College of Medicine wants to better identify which patients with pleural mesothelioma cancer will benefit (and which will not) from promising immunotherapy drugs such as Keytruda and Opdivo. No test currently exists to make that determination accurately, often leading to unnecessary treatments with adverse side effects and…

The post Study: Which Mesothelioma Patients Will Immunotherapy Benefit? appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Winter Storm Delays Cancer Treatment Across U.S.

Severe winter storms have affected multiple central U.S. states with power outages and water supply disruptions. State officials in Texas, Louisiana and Mississippi say restoring power to everyone could still take several days. Over the past week, problems with state infrastructure left millions of residents across Texas and Oklahoma without heat and potable water. Dr. […]

The post Winter Storm Delays Cancer Treatment Across U.S. appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Winter Storm Delays Cancer Treatment Across U.S.

Severe winter storms have affected multiple central U.S. states with power outages and water supply disruptions. State officials in Texas, Louisiana and Mississippi say restoring power to everyone could still take several days. Over the past week, problems with state infrastructure left millions of residents across Texas and Oklahoma without heat and potable water. Dr….

The post Winter Storm Delays Cancer Treatment Across U.S. appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.